openPR Logo
Press release

Aquigen Bio Launches High-Purity Impurity Standards for Pizotifen, Padimate-O & Pacritinib

06-26-2025 01:04 PM CET | Chemicals & Materials

Press release from: Aquigen Bio Sciences

Aquigen Bio Launches High-Purity Impurity Standards

Aquigen Bio, a trusted provider of pharmaceutical reference standards and research tools, is pleased to announce the launch of new impurity standards for three critical pharmaceutical and cosmeceutical compounds: Pizotifen, Padimate-O, and Pacritinib.

As the pharmaceutical and personal care industries face growing regulatory scrutiny and an increasing demand for analytical precision, Aquigen Bio continues to deliver certified reference materials (CRMs) that empower laboratories to meet quality benchmarks and support safe, compliant product development.

Newly Released Impurity Standards

Pizotifen Impurity Standards
Used primarily in the prevention of vascular headaches such as migraines, Pizotifen's impurity profiling is essential for maintaining its therapeutic integrity and patient safety. Aquigen Bio now provides validated impurities to support method development, stability studies, and routine QC analysis.

https://aquigenbio.com/products/impurity-standards/pizotifen/

Padimate-O Impurity Standards
A widely used UV-B absorber in sunscreens and skincare formulations, Padimate-O is regulated for both safety and effectiveness. The availability of high-purity impurity standards enables manufacturers and analytical labs to meet regulatory specifications with confidence.

https://aquigenbio.com/products/impurity-standards/padimate-o/

Pacritinib Impurity Standards
As a JAK2/FLT3 inhibitor used in myelofibrosis and hematologic malignancies, Pacritinib's impurity detection is crucial due to its sensitive therapeutic application. Aquigen Bio's impurity standards aid in precise quantification and quality assurance of oncological formulations.

https://aquigenbio.com/products/impurity-standards/pacritinib/

Why Impurity Standards Matter More Than Ever
With global regulations tightening and patient safety as the foremost priority, pharmaceutical and cosmetic manufacturers must validate the purity, stability, and composition of active pharmaceutical ingredients (APIs) and excipients more thoroughly than ever.

Aquigen Bio's impurity standards offer:
Analytical Reliability - Fit-for-purpose CRMs validated for use in LC-MS, HPLC, GC, and other analytical techniques
Regulatory Readiness - CoA-supported standards that comply with international guidelines (ICH, USP, EP, JP)

Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Visit: www.aquigenbio.com

Aquigen Bio Sciences stands as India's premier resource for high-quality N-Nitroso impurity standards, impelling advancements in pharmaceutical research and manufacturing. Specializing in providing precise impurity standards - including degradation impurities, process impurities, and deuterated isotopes - Aquigen Bio Sciences empowers the industry to comply with the most rigorous global regulations. The contract research organization's commitment to precision and reliability makes it the trusted partner for addressing complex issues like N-Nitroso impurities in pharmaceuticals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aquigen Bio Launches High-Purity Impurity Standards for Pizotifen, Padimate-O & Pacritinib here

News-ID: 4083199 • Views:

More Releases from Aquigen Bio Sciences

Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Development, Quality Control, and Regulatory Compliance in Pharmaceutical Research
Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Dev …
Estradiol Valerate EP Impurity A is a high-quality reference standard designed to meet the stringent requirements of pharmaceutical research, method validation, and quality control processes. Explore Estradiol Valerate EP Impurity A : https://aquigenbio.com/product/estradiol-valerate-ep-impurity-a/ Manufactured and characterized with precision, this impurity standard supports laboratories and manufacturers in achieving consistent, reliable, and reproducible results in critical analytical workflows. With its exceptional purity and accurate characterization, Estradiol Valerate EP Impurity A plays a vital role
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deuterated Nitrosamine Impurity Standard for Method Development, Validation, Quality Control, and Regulatory Submissions in Betahistine Impurity Profiling and Research
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications. https://aquigenbio.com/product/n-nitroso-betahistine-d3/ Key Features and Benefits Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control. Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.
Elevating Analytical Precision with Harmine Impurity Standards
Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance. Why Harmine Impurity Standards Matter https://aquigenbio.com/products/impurity-standards/harmine/ Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has

All 5 Releases


More Releases for Impurity

Tizanidine Nitroso Impurity 1 - High-Purity Reference Standard for Reliable Impu …
In the highly regulated world of pharmaceutical manufacturing, impurity profiling plays a critical role in ensuring drug safety, efficacy, and regulatory compliance. Among the wide range of impurity reference standards required during API development and validation, Tizanidine Nitroso Impurity 1 stands out as a vital compound for researchers and manufacturers working on Tizanidine-based formulations. At Aquigen Bio, we are proud to offer Tizanidine Nitroso Impurity 1, a high-purity reference standard meticulously
AquigenBio Launches High-Purity EP Impurity Standards for Propylthiouracil, Incl …
AquigenBio is pleased to announce the availability of two essential impurity reference standards-Propylthiouracil EP Impurity A and Propylthiouracil EP Impurity B. These impurity standards are now available to support pharmaceutical companies, contract research organizations, and analytical laboratories engaged in drug development, quality control, and regulatory compliance. Propylthiouracil (PTU) is a well-known antithyroid medication, widely used in the treatment of hyperthyroidism. In line with pharmacopeial guidelines, it is critical to identify and
Precision in Impurity Profiling: Aquigen Bio Introduces High-Purity Doxorubicin …
Pune, India - July 2025 - As regulatory standards tighten across the pharmaceutical industry, the need for accurate, high-purity reference standards has never been more critical. Aquigen Bio, a trusted provider of pharmaceutical reference materials, is proud to announce the availability of Doxorubicin Dimer Impurity 3, a key impurity used in the impurity profiling of the widely used chemotherapeutic agent, Doxorubicin. This launch is part of Aquigen Bio's expanded portfolio of
Breaking Ground in Pharmaceutical Impurity Standards: Aquigen Bio Expands Abirat …
In the evolving landscape of pharmaceutical development and quality control, the identification, synthesis, and supply of high-purity impurity standards play a pivotal role. One of the most significant advancements in recent times is the availability of specialized Abiraterone-related impurity standards-essential tools for characterizing drug formulations and ensuring regulatory compliance. Manufactured and supplied by Aquigen BioSciences, a trusted leader in impurity synthesis and reference standards, these impurity standards offer analytical laboratories and
Unlock Advanced Dabigatran Research with High-Purity Standards: Now Available - …
In the ever-evolving pharmaceutical landscape, precision, safety, and regulatory compliance have never been more crucial. With Dabigatran etexilate mesylate becoming a cornerstone in the management of thromboembolic disorders, the demand for high-purity standards and robust impurity profiling has surged. Recognizing this essential need, a new suite of advanced analytical tools for Dabigatran and its associated impurities has been made available to support the global scientific and quality control community. To kno
Aquigen Bio Expands Oncology Impurity Standards Portfolio with High-Purity Etopo …
India - 07/05/2025 - Aquigen Bio, a leading provider of pharmaceutical impurity reference standards, proudly announces the launch of its latest high-quality product: Etoposide EP Impurity A. This new addition to Aquigen's growing portfolio of oncology-related impurities is tailored to meet the stringent requirements of pharmaceutical manufacturers and analytical laboratories focused on drug safety, efficacy, and compliance. To know more about : Etoposide EP Impurity A https://aquigenbio.com/product/etoposide-ep-impurity-a/ A Strategic Addition to Oncology Drug